At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02509 QYUNS-B
Not Yet Opened 06-05 16:09:12
15.230
-0.380
-2.43%
High15.800Low14.630Vol609.00K
Open15.610D1 Closing15.610Amplitude7.50%
Mkt Cap3.41BTradable Cap3.41BTotal Shares224.00M
T/O9.20MT/O Rate0.27%Tradable Shares224.00M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Qyuns Therapeutics buys back 253,200 H-shares for HK$3.83 million, trimming free float by 0.11%
Bulletin Express  ·  06-05 20:43
Qyuns Therapeutics buys back 253,200 H-shares for HK$3.83 million, trimming free float by 0.11%
QYUNS-B (02509) Allocates HK$3.826 Million for Share Buyback on June 5
Stock News  ·  06-05 20:30
QYUNS-B (02509) Allocates HK$3.826 Million for Share Buyback on June 5
Qyuns Therapeutics files HKEX next-day return disclosing share buyback at HKD 15.11 per share
Reuters  ·  06-05 20:26
Qyuns Therapeutics files HKEX next-day return disclosing share buyback at HKD 15.11 per share
QYUNS-B Allocates HK$391,900 for Share Buyback on June 4
Stock News  ·  06-04
QYUNS-B Allocates HK$391,900 for Share Buyback on June 4
QYUNS-B repurchases 25,200 H shares for HKD 0.39 million, treasury stock rises to 3.07 million
Bulletin Express  ·  06-04
QYUNS-B repurchases 25,200 H shares for HKD 0.39 million, treasury stock rises to 3.07 million
QYUNS-B trims outstanding shares by 0.09% in May through HK$3.35 million repurchases, maintains public float compliance
Bulletin Express  ·  06-04
QYUNS-B trims outstanding shares by 0.09% in May through HK$3.35 million repurchases, maintains public float compliance
QYUNS-B buys back 0.11 million H-shares; treasury stock rises to 3.05 million units
Bulletin Express  ·  06-03
QYUNS-B buys back 0.11 million H-shares; treasury stock rises to 3.05 million units
QYUNS-B Executes Share Buyback, Spending HKD 1.69 Million
Stock News  ·  06-03
QYUNS-B Executes Share Buyback, Spending HKD 1.69 Million
Qyuns Therapeutics buys back 57,200 H-shares; treasury stock climbs to 2.94 million
Bulletin Express  ·  06-02
Qyuns Therapeutics buys back 57,200 H-shares; treasury stock climbs to 2.94 million
QYUNS-B (02509) Repurchases 174,400 Shares for Approximately HK$2.81 Million on June 1
Stock News  ·  06-01
QYUNS-B (02509) Repurchases 174,400 Shares for Approximately HK$2.81 Million on June 1
Qyuns Therapeutics Buys Back 174,400 H-Shares, Expands Treasury Stock to 2.88 Million Shares
Bulletin Express  ·  06-01
Qyuns Therapeutics Buys Back 174,400 H-Shares, Expands Treasury Stock to 2.88 Million Shares
Qyuns Therapeutics Updates Articles of Association: Clarifies Share Structure, Governance Framework and Dividend Policy
Bulletin Express  ·  05-29
Qyuns Therapeutics Updates Articles of Association: Clarifies Share Structure, Governance Framework and Dividend Policy
Qyuns Therapeutics dissolves supervisory committee as supervisors resign
Reuters  ·  05-29
Qyuns Therapeutics dissolves supervisory committee as supervisors resign
Qyuns Therapeutics repurchases 70,000 H-shares; treasury stock rises to 2.71 million units
Bulletin Express  ·  05-28
Qyuns Therapeutics repurchases 70,000 H-shares; treasury stock rises to 2.71 million units
BRIEF-Qyuns Therapeutics Co Receives Milestone Payment From Roche
Reuters  ·  05-27
BRIEF-Qyuns Therapeutics Co Receives Milestone Payment From Roche
QYUNS-B Receives Milestone Payment from Roche Following First Patient Dosing in Phase I Trial for QX031N
Stock News  ·  05-27
QYUNS-B Receives Milestone Payment from Roche Following First Patient Dosing in Phase I Trial for QX031N
Qyuns Therapeutics receives Roche milestone payment after first QX031N Phase I patient dosed
Reuters  ·  05-27
Qyuns Therapeutics receives Roche milestone payment after first QX031N Phase I patient dosed
Qyuns Therapeutics Co - Receives Milestone Payment From Roche for First Participant Dosed in Phase I QX031n Trial
THOMSON REUTERS  ·  05-27
Qyuns Therapeutics Co - Receives Milestone Payment From Roche for First Participant Dosed in Phase I QX031n Trial
QYUNS-B (02509) Allocates HK$2.19 Million for Share Buyback on May 27
Stock News  ·  05-27
QYUNS-B (02509) Allocates HK$2.19 Million for Share Buyback on May 27
Qyuns Therapeutics files HKEX next-day return disclosing share repurchase at HKD 16.31 each
Reuters  ·  05-27
Qyuns Therapeutics files HKEX next-day return disclosing share repurchase at HKD 16.31 each

Introduction

Company Name.
QYUNS-B
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
Qyuns Therapeutics Co Ltd is a China-based company principally engaged in the research and development, manufacturing and commercialisation of biologic therapies for autoimmune and allergic diseases. The Company focuses on dermatology, respiratory, gastroenterology and rheumatology diseases. The Company's products include SAILEXIN, Oturkibart, and Crusekitug. The Company conducts its businesses in domestic and overseas markets.
Issue price:
--